coflex
Commercial- Indications
- Spinal stenosis, Back pain, Leg pain
Company intelligence / Profile preview
Paradigm Spine has developed a comprehensive portfolio of minimally invasive spinal implant solutions for both fusion and non-fusion procedures. Its flagship product Coflex® Interlaminar Stabilization® has demonstrated durable pain relief and stability in long-term clinical studies. The company continues to innovate with new devices such as Fortilink® interbody fusion systems using advanced titanium technology. Clinical results for Coflex® are supported by FDA PMA approval and published peer-reviewed data. The company’s products are widely used globally.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paradigm Spine.